Rational design of potent sialidase-based inhibitors of influenza virus replication

Cited by (1,001)

Items 701–800 of 1,001

1. Genetic Analysis Reveals That Both Haemagglutinin and Neuraminidase Determine the Sensitivity of Naturally Occurring Avian Influenza Viruses to Zanamivir in Vitro
   Susan J. Baigent, Richard C. Bethell, John W. McCauley · 1999 · Virology
2. Synthetic Efforts for Stereo Structure Determination of Cytotoxic Marine Natural Product Pericosines as Metabolites of Periconia sp. from Sea Hare
   Yoshihide Usami, Hayato Ichikawa, Masao Arimoto · 2008 · International Journal of Molecular Sciences
3. Hydrophobic benzoic acids as inhibitors of influenza neuraminidase
   Venkatram R. Atigadda, Wayne J. Brouillette, Franco J. Duarte, Yarlagadda S. Babu, Shanta Bantia, Pooran Chand, Naiming Chu, John A. Jr. Montgomery, David Andrew Walsh, Elise A. Sudbeck et al. · 1999 · Bioorganic & Medicinal Chemistry
4. The synthesis of novel sialic acids as biological probes
   Mark von Itzstein, Robin J. Thomson · 1997 · Topics in current chemistry
5. Mutations Affecting the Sensitivity of the Influenza Virus Neuraminidase to 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic Acid
   Hideo Goto, Richard C. Bethell, Yoshihiro Kawaoka · 1997 · Virology
6. International Journal of Chemistry and Pharmaceutical Sciences
   Publisher Ramesh Dhani · 2014 · ADVANCED SCIENCES INDEX
7. Functional and Structural Analysis of Influenza Virus Neuraminidase N3 Offers Further Insight into the Mechanisms of Oseltamivir Resistance
   Qing Li, Jianxun Qi, Yan Wu, Hiromasa Kiyota, Kosuke Tanaka, Yoshitomo Suhara, Hiroshi Ohrui, Yasuo Suzuki, Christopher John Vavricka, George F. Gao · 2013 · Journal of Virology
8. Chapter 1 Looking Back in 2009 at the Dawning of Antiviral Therapy Now 50 Years Ago
   Erik De Clercq · 2009 · Advances in virus research
9. Efficient and Stereodivergent Syntheses of D ‐ and L ‐Fagomines and Their Analogues
   Nitee Kumari, B. Gopal Reddy, Yashwant D. Vankar · 2008 · European Journal of Organic Chemistry
10. Sialylation regulates myofibroblast differentiation of human skin fibroblasts
    Norihiko Sasaki, Yoko Itakura, Masashi Toyoda · 2017 · Stem Cell Research & Therapy
11. An alternative synthesis of Tamiflu®: a synthetic challenge and the identification of a ruthenium-catalyzed dihydroxylation route
    Kenzo Yamatsugu, Motomu Kanai, Masakatsu Shibasaki · 2009 · Tetrahedron
12. The First l -Iduronic Acid-Type 1-N-Iminosugars Having Inhibitory Activity of Experimental Metastasis
    Yoshio Nishimura, Takahiko Satoh, Hayamitsu Adachi, Shinichi Kondo, TOMIO TAKEUCHI, Masayuki AZETAKA, HARUMI FUKUYASU, Yumiko Iizuka · 1996 · Journal of the American Chemical Society
13. Cloud Infrastructures for In Silico Drug Discovery: Economic and Practical Aspects
    Daniele D’Agostino, Andrea Clematis, Alfonso Quarati, Daniele Cesini, Federica Chiappori, Luciano Milanesi, Ivan Merelli A · 2013 · BioMed Research International
14. Small molecule inhibitors of mammalian glycosylation
    Karim Almahayni, Malte Spiekermann, Antonio Fiore, G. Yu, Kayvon Pedram, Leonhard Möckl · 2022 · Matrix Biology Plus
15. Computationally and Experimentally Derived General Rules for Fragmentation of Various Glycosyl Bonds in Sodium Adduct Oligosaccharides
    Hiroaki Suzuki, Akihiko Kameyama, Kazuo Tachibana, Hisashi Narimatsu, Kazuhiko Fukui · 2008 · Analytical Chemistry
16. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities
    Chien‐Hung Lin, Tsung-Che Chang, Anindya Das, Mingyu Fang, Hui‐Chen Hung, Kai‐Cheng Hsu, Jinn‐Moon Yang, Mark von Itzstein, Kwok Kong Tony Mong, Tsu‐An Hsu et al. · 2013 · Organic & Biomolecular Chemistry
17. Organocatalytic and Scalable Synthesis of the Anti‐Influenza Drugs Zanamivir, Laninamivir, and CS‐8958
    Junshan Tian, Jiankang Zhong, Yunsheng Li, Dawei Ma · 2014 · Angewandte Chemie International Edition
18. Signature peptides of influenza nucleoprotein for the typing and subtyping of the virus by high resolution mass spectrometry
    Alexander B. Schwahn, Jason W.H. Wong, Kevin M. Downard · 2009 · The Analyst
19. Faecal mucinase activity assessed in inflammatory bowel disease using 14C threonine labelled mucin substrate.
    A D Dwarakanath, Barry James Campbell, H. H. Tsai, D. Sunderland, C. Anthony Hart, Jonathan Michael Rhodes · 1995 · Gut
20. Intracellular trafficking of influenza virus: clinical implications for molecular medicine
    Gary R. Whittaker · 2001 · Expert Reviews in Molecular Medicine
21. Targeting influenza virus neuraminidase—a new strategy for antiviral therapy
    JOHN S. OXFORD, Rob Lambkin‐Williams · 1998 · Drug Discovery Today
22. Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients
    Adrian D. Griffin, Andrew Perry, Douglas Fleming · 2001 · PharmacoEconomics
23. The 1.8 å structures of leech intramolecular trans -sialidase complexes: evidence of its enzymatic mechanism 1 1Edited by R. Huber
    Yu Luo, Su‐Chen Li, Y T Li, Ming Luo · 1999 · Journal of Molecular Biology
24. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment
    Julia Hoffmann, Carola Schneider, Lena Heinbockel, Klaus Brandenburg, Rudolph Reimer, Gülşah Gabriel · 2014 · Antiviral Research
25. Structure-based drug discovery and protein targets in the CNS
    Roderick E. Hubbard · 2010 · Neuropharmacology
26. Exploring the chemical space of influenza neuraminidase inhibitors
    Nuttapat Anuwongcharoen, Watshara Shoombuatong, Tanawut Tantimongcolwat, Virapong Prachayasittikul, Chanin Nantasenamat · 2016 · PeerJ
27. A Modified Preparation Procedure for Carbon Nanotube-Confined Nd/Na Heterobimetallic Catalyst for anti-Selective Catalytic Asymmetric Nitroaldol Reactions
    Devarajulu Sureshkumar, Kazuki Hashimoto, Naoya Kumagai, Masakatsu Shibasaki · 2013 · The Journal of Organic Chemistry
28. Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus
    Jana Pokorná, Petr Pachl, Elena Karlukova, Jakub Hejdánek, Pavlína Řezáčová, Aleš Machara, Jason Reed Hudlicky, Jan Konvalinka, Milan Kožíšek · 2018 · Viruses
29. Review on Newcastle disease in poultry
    Koffi Francois-Xavier Dzogbema, Essodina Talaki, K. Batawui, Balabadi Dao · 2021 · International Journal of Biological and Chemical Sciences
30. Calyceramides A–C: neuraminidase inhibitory sulfated ceramides from the marine sponge Discodermia calyx
    Yoichi Nakao, Kentaro Takada, Shigeki Matsunaga, Nobuhiro Fusetani · 2001 · Tetrahedron
31. Interaction of zanamivir with DNA and RNA: Models for drug–DNA and drug–RNA bindings
    Shohreh Nafisi, Fatemeh Ghoreyshi Kahangi, Ebrahim Azizi, Nader Zebarjad, Heidar‐Ali Tajmir‐Riahi · 2006 · Journal of Molecular Structure
32. Design and synthesis of 1,2,3-triazole-containing N -acyl zanamivir analogs as potent neuraminidase inhibitors
    Anindya Das, Avijit Kumar Adak, Kalyana Kumar Ponnapalli, Chien-Hung Lin, Kai‐Cheng Hsu, Jinn‐Moon Yang, Tsu‐An Hsu, Chun‐Cheng Lin · 2016 · European Journal of Medicinal Chemistry
33. Multivalent oleanolic acid human serum albumin conjugate as nonglycosylated neomucin for influenza virus capture and entry inhibition
    Yang Yang, Hao-Jie He, Hao Chang, Yao Yu, Mei-Bing Yang, Yun He, Zhen‐Chuan Fan, Suri S. Iyer, Peng Yu · 2017 · European Journal of Medicinal Chemistry
34. Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors
    Pramod C. Nair, Masilamani Elizabeth Sobhia · 2007 · European Journal of Medicinal Chemistry
35. Therapeutic options for the management of influenza
    Michael G. Ison · 2001 · Current Opinion in Pharmacology
36. Approaches to carbocyclic analogues of the potent neuraminidase inhibitor 4-guanidino-Neu5Ac2en. X-Ray molecular structure of N-[(1S,2S,6R)-2-azido-6-benzyloxymethyl-4-formylcyclohex-3-enyl]acetamide
    Malcolm Chandler, Richard Conroy, Anthony W. J. Cooper, R. Brian Lamont, Jan J. Scicinski, James E. Smart, Richard Storer, Niall G. Weir, Richard D. Wilson, Paul Graham Wyatt · 1995 · Journal of the Chemical Society Perkin Transactions 1
37. Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice
    Roger A. Burger, Jonna L Billingsley, John H. Huffman, Kevin W. Bailey, Choung U. Kim, Robert W. Sidwell · 2000 · Immunopharmacology
38. Computational tools for structure-based ligand design
    Hans‐Joachim Böhm · 1996 · Progress in Biophysics and Molecular Biology
39. Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
    Toshiyuki Hikita, Hiroyuki Hikita, Fusako Hikita, Naoko Hikita, Shizue Hikita · 2012 · International Journal of Pediatrics
40. Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
    Ly Le, Eric Lee, Klaus J. Schulten, Thanh N. Truong · 2010 · PLoS Currents
41. From Neuraminidase Inhibitors to Conjugates: A Step Towards Better Anti-Influenza Drugs?
    Chung‐Kai Cheng, Chen-Hsuan Tsai, Jiun‐Jie Shie, Jim‐Min Fang · 2014 · Future Medicinal Chemistry
42. Molecular Docking Methodologies
    Andrea Bortolato, Marco Fanton, Jonathan S. Mason, Stefano Moro · 2012 · Methods in molecular biology
43. The Role of Functional Groups in Drug–Receptor Interactions
    Laurent Schaeffer · 2008 · Elsevier eBooks
44. Discovery of Novel Benzoquinazolinones and Thiazoloimidazoles, Inhibitors of Influenza H5N1 and H1N1 Viruses, from a Cell-Based High-Throughput Screen
    Joseph A. Maddry, Xi Chen, Colleen Beth Jonsson, Subramaniam Ananthan, Judith Varady Hobrath, Donald F. Smee, James W. Noah, Diana L. Noah, Xiaolin Xu, Fuli Jia et al. · 2010 · SLAS DISCOVERY
45. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry
    Bethny Morrissey, Margaret Streamer, Kevin M. Downard · 2007 · Journal of Virological Methods
46. Assessment of Development of Resistance to Antivirals in the Ferret Model of Influenza Virus Infection
    M. Louise Herlocher, Rachel Truscon, Rob J. Fenton, Alexander I Klimov, Stephanie Elias, Suzanne E. Ohmit, Arnold S. Monto · 2003 · The Journal of Infectious Diseases
47. Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping
    Wayne J. Brouillette, Venkatram R. Atigadda, Ming Luo, Gillian M. Air, Yarlagadda S. Babu, Shanta Bantia · 1999 · Bioorganic & Medicinal Chemistry Letters
48. Production of N-acetyl-D-neuraminic acid using two sequential enzymes overexpressed as double-tagged fusion proteins
    Tzu‐Hsien Wang, Ying-Yin Chen, Hsin‐Hung Pan, Feng-Pao Wang, Chung‐Hsien Cheng, Wen‐Chien Lee · 2009 · BMC Biotechnology
49. The Origin and Control of Pandemic Influenza
    William Graeme Laver, Norbert Bischofberger, R. G. Webster · 2000 · Perspectives in biology and medicine
50. Synthesis of hybrids of d-glucose and d-galactose with 1-deoxynojirimycin analogues using ring-closing metathesis
    Amit Kumar, Girish K. Rawal, Yashwant D. Vankar · 2008 · Tetrahedron
51. Effect of Renal Impairment on the Pharmacokinetics of Intravenous Zanamivir
    Lindsey Cass, Constantin Efthymiopoulos, Julie Marsh, Alan Bye · 1999 · Clinical Pharmacokinetics
52. Chimeric Nectin1-Poliovirus Receptor Molecules Identify a Nectin1 Region Functional in Herpes Simplex Virus Entry
    Francesca Cocchi, Marc Lopez, Patrice C. Dubreuil, Gabriella Campadelli‐Fiume, Laura Menotti · 2001 · Journal of Virology
53. The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
    Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu · 2023 · mBio · Retracted
54. Assessing Molecular Docking Tools for Relative Biological Activity Prediction: A Case Study of Triazole HIV-1 NNRTIs
    Tomasz M. Frączek, Agata Siwek, Piotr Paneth · 2013 · Journal of Chemical Information and Modeling
55. Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study
    Irina A. Leneva, Irina N. Falynskova, Nailya R. Makhmudova, А. А. Поромов, S. B. Yatsyshina, Maleev Vv · 2018 · Journal of Medical Virology
56. Design, synthesis and biological evaluation of “Multi-Site”-binding influenza virus neuraminidase inhibitors
    Ruifang Jia, Jian Zhang, Wei Ai, Xiao Ding, Samuel Desta, Lin Sun, Zhuosen Sun, Xiuli Ma, Zhong Li, Defeng Wang et al. · 2019 · European Journal of Medicinal Chemistry
57. A new asymmetric synthetic route to substituted piperidines
    Majjigapu Somi Reddy, M. Narender, K. Rama Rao · 2006 · Tetrahedron
58. Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors
    Xiang Yi, Zongru Guo, Fengming Chu · 2003 · Bioorganic & Medicinal Chemistry
59. Exploitation of the Catalytic Site and 150 Cavity for Design of Influenza A Neuraminidase Inhibitors
    Pal John Pal Adabala, Eric B. LeGresley, Nicole Bance, Masahiro Niikura, Bernardine M. Pinto · 2013 · The Journal of Organic Chemistry
60. Equine Influenza Infection
    Grabriele A. Landolt, Hugh G.G. Townsend, David Paul Lunn · 2013 · Elsevier eBooks
61. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses
    Jennifer A. Pickens, Ralph A. Tripp · 2018 · Viruses
62. Structural and functional-group tuning in the design of neuraminidase inhibitors
    Subramaniam Sabesan, Susana Neira, Zelda R. Wasserman · 1995 · Carbohydrate Research
63. Conserved motifs in T-cell receptor CDR1 and CDR2: implications for ligand and CD8 co-receptor binding
    Bernhard Arden · 1998 · Current Opinion in Immunology
64. Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus
    Makoto Murakami, Kiyoshi Ikeda, Kazuo Achiwa · 1996 · Carbohydrate Research
65. Glycosyl Transferase Mechanisms
    David L. Zechel, Stephen G. Withers · 1999 · Elsevier eBooks
66. The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans
    Yuki Suzaki, Naoto Uemura, Makoto Takada, Tetsuji Ohyama, Akiko Itohda, Takuya Morimoto, Hiromitsu Imai, Hajime Hamasaki, Akihiro Inano, Masakiyo Hosokawa et al. · 2012 · European Journal of Clinical Pharmacology
67. In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir
    Jennifer L. McKimm‐Breschkin, Christina L. Rootes, Peter G. Mohr, Susan Barrett, Victor A. Streltsov · 2012 · Journal of Antimicrobial Chemotherapy
68. Mechanisms of Enzymatic Glycosyl Transfer
    Ran Zhang, Vivian L. Y. Yip, Stephen G. Withers · 2010 · Elsevier eBooks
69. Oseltamivir analogs with potent anti-influenza virus activity
    Sumit Kumar, Steven Goicoechea, Sonu Kumar, Catherine M. Pearce, Ravi V. Durvasula, Prakasha M Kempaiah, Brijesh Rathi, Poonam Poonam · 2020 · Drug Discovery Today
70. Facile and Efficient Synthesis of Carbohybrids as Stereodivergent Druglike Small Molecules
    Ram Sagar, Seung Bum Park · 2008 · The Journal of Organic Chemistry
71. I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses
    Jennifer L. McKimm‐Breschkin, Susan Barrett, Pudjiatmoko, Muhammad Azhar, Frank Y. K. Wong, Paul Selleck, Peter G. Mohr, James McGrane, Mia Kim · 2013 · PLoS ONE
72. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2
    Zahra Khedri, Yanhong Li, Hongzhi Cao, Jingyao Qu, Hai Yu, Musleh M. Muthana, Xi Chen · 2012 · Organic & Biomolecular Chemistry
73. Synthesis and evaluation of influenza A viral neuraminidase candidate inhibitors based on a bicyclo[3.1.0]hexane scaffold
    Cinzia Colombo, Bernardine M. Pinto, Anna Bernardi, Andrew J. Bennet · 2016 · Organic & Biomolecular Chemistry
74. Glycosidase Inhibitors: Structure, Activity, Synthesis, and Medical Relevance
    Mikael Bols, Óscar López, Fernando Ortega‐Caballero · 2007 · Elsevier eBooks
75. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
    Maryna C. Eichelberger, Arash Hassantoufighi, Meng Wu, Min Li · 2008 · Virology Journal
76. A SYNTHESIS OF 4-α-GUANIDINO-2-DEOXY-2,3-DIDEHYDRO N-ACETYLNEURAMINIC ACID
    John Scheigetz, Robert J. Zamboni, Michael A. Bernstein, Bruno Roy · 1995 · Organic Preparations and Procedures International
77. The first synthesis of a C-7 nitrogen-containing sialic acid analogue, acid (7-azido-7-deoxy-Neu5Ac)
    David C. M. Kong, Mark von Itzstein · 1995 · Tetrahedron Letters
78. Synthesis of transition-state analogues as potential inhibitors of sialidase from Influenza virus
    Pierre‐Alexandre Driguez, Béatrice Barrere, G Quash, Alain Doutheau · 1994 · Carbohydrate Research
79. NMR investigations of glycan conformation, dynamics, and interactions
    Jesús Angulo, Ana Ardá, Sara Bertuzzi, Ángeles Canales, June Ereño‐Orbea, Ana Gimeno, Marcos Gómez‐Redondo, Juan Carlos Muñoz-García, Paola Oquist-Phillips, Serena Monaco et al. · 2024 · Progress in Nuclear Magnetic Resonance Spectroscopy
80. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model
    Lili Shi, Yue Zhou Cao, Xiao-Yin Zhu, Jing-Hao Cui, Qing‐Ri Cao · 2014 · International Journal of Pharmaceutics
81. Design and synthesis of anti-cancer cyclopeptides containing triazole skeleton
    Fatemeh Tahoori, Saeed Balalaie, Reza G. Sheikhnejad, Mahnaz Sadjadi, Parvin Boloori · 2014 · Amino Acids
82. Clinical Pharmacokinetics of Inhaled Antimicrobials
    Chris R. Stockmann, Jessica K. Roberts, Venkata Yellepeddi, Catherine M.T. Sherwin · 2015 · Clinical Pharmacokinetics
83. A Gibbs free energy correlation for automated docking of carbohydrates
    Anthony D. Hill, Peter J. Reilly · 2007 · Journal of Computational Chemistry
84. Combined Quantum Mechanics/Molecular Mechanics (QM/MM) Simulations for Protein–Ligand Complexes: Free Energies of Binding of Water Molecules in Influenza Neuraminidase
    Christopher J. Woods, Katherine E. Shaw, Adrian John Mulholland · 2014 · The Journal of Physical Chemistry B
85. Exploring the Cause of Oseltamivir Resistance Against Mutant H274Y Neuraminidase by Molecular Simulation Approach
    Karthick Vasudevan, Shanthi Veerappapillai, Ramalingam Rajasekaran, K. Ramanathan · 2012 · Applied Biochemistry and Biotechnology
86. Plasticity of 150-Loop in Influenza Neuraminidase Explored by Hamiltonian Replica Exchange Molecular Dynamics Simulations
    Nanyu Han, Yuguang Mu · 2013 · PLoS ONE
87. Synthesis of a carbocyclic sialic acid analogue for the inhibition of influenza virus neuraminidase
    Armandodoriano Bianco, Mario Brufani, Fedele Manna, Cristiana Melchioni · 2001 · Carbohydrate Research
88. Tamiphosphor monoesters as effective anti-influenza agents
    Chun‐Lin Chen, T. Lin, Shiyun Wang, Jiun‐Jie Shie, Keng‐Chang Tsai, Yih‐Shyun E. Cheng, Jia‐Tsrong Jan, Chun-Jung Lin, Jim-Min Fang, Chi‐Huey Wong · 2014 · European Journal of Medicinal Chemistry
89. B(C6F5)3 as versatile catalyst: an efficient and mild protocol for the one-pot synthesis of functionalized piperidines and 2-substituted benzimidazole derivatives
    Santosh Kumar Prajapti, Atulya Nagarsenkar, Sravanthi Devi Guggilapu, Bathini Nagendra Babu · 2015 · Tetrahedron Letters
90. Antiviral drugs fit for a purpose
    Ming Luo · 2006 · Nature
91. Structure-Based Ligand Design
    Klaus Gubernator, Clemens Broger, Daniel Bur, Daniel M. Doran, Paul R. Gerber, K. Müller, Th. M. Schaumann · 1995 · Springer eBooks
92. Synthesis of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified at the C-4 and C-9 positions and their behaviour towards sialidase from influenza virus and pig liver membrane
    Kiyoshi Ikeda, Kimihiko Sano, Masaki Ito, Megumi Saito, Kazuya I.P.J. Hidari, Takashi Suzuki, Yasuo Suzuki, Kiyoshi Tanaka · 2001 · Carbohydrate Research
93. Enzyme Molecular Mechanism as a Starting Point to Design New Inhibitors: A Theoretical Study of O-GlcNAcase
    Jerônimo Lameira, Cláudio Nahum Alves, Iñaki Tuñón, Sergio Martı́, Vicent Moliner · 2011 · The Journal of Physical Chemistry B
94. Zwitterionic Structures: From Physicochemical Properties Toward Computer-Aided Drug Designs
    Zhiwei Yang, Qinyi Li, Gang Yang · 2016 · Future Medicinal Chemistry
95. Asteropine A, a Sialidase-Inhibiting Conotoxin-like Peptide from the Marine Sponge Asteropus simplex
    Kentaro Takada, Toshiyuki Hamada, Hiroshi Hirota, Yoichi Nakao, Shigeki Matsunaga, Rob W. M. van Soest, Nobuhiro Fusetani · 2006 · Chemistry & Biology
96. Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs)
    Marija L. Mihajlović, Petar M. Mitrašinović · 2008 · Molecular Simulation
97. Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate
    Anna Lundin, Tomas B. Bergström, Carla Regina Andrighetti, Loubna Bendrioua, Vito Ferro, Edward Trybala · 2011 · Antiviral Research
98. In silico screening of molecular imprinting prepolymerization systems: oseltamivir selective polymers through full-system molecular dynamics-based studies
    Siamak Shoravi, Gustaf D. Olsson, Björn C. G. Karlsson, Fredrik Bexborn, Younes Abghoui, Javed Hussain, Jesper G. Wiklander, Ian A. Nicholls · 2016 · Organic & Biomolecular Chemistry
99. In Vivo Veritas: 18F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 Inhibitors
    Klas Bratteby, Edvard Torkelsson, Elina Tampio L’Estrade, Kristoffer Peterson, Vladimir Shalgunov, Mengfei Xiong, Hakon Leffler, Fredrik R. Zetterberg, Tomas G. Olsson, Nic Gillings et al. · 2019 · Journal of Medicinal Chemistry
100. Zanamivir: an influenza virus neuraminidase inhibitor
     P.M. Colman · 2005 · Expert Review of Anti-infective Therapy